Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Maria Brown to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- City of Hope Medical Center, Duarte, California, 91010
- City of Hope Comprehensive Cancer Center, Duarte, California, 91010
- University of California at Davis Cancer Center, Sacramento, California, 95817
- University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817
-
Arizona
- Arizona Cancer Center at University Medical Center North, Tucson, Arizona, 85719
- University of Arizona Health Sciences Center, Tucson, Arizona, 85724
-
Colorado
- University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora, Colorado, 80045
-
Texas
- University Hospital, San Antonio, Texas, 78229
- University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229
- Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas, 78229
- Audie L Murphy Veterans Affairs Hospital, San Antonio, Texas, 78209
- M D Anderson Cancer Center, Houston, Texas, 77030
-
Illinois
- Central Illinois Hematology Oncology Center, Springfield, Illinois, 62702
- Illinois CancerCare-Peoria, Peoria, Illinois, 61615
- Loyola University Medical Center, Maywood, Illinois, 60153
-
Indiana
- Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne, Indiana, 46845
Powered by
SC CTSI